329 related articles for article (PubMed ID: 32647978)
1. Association of bullous pemphigoid and comorbid health conditions: a case-control study.
Lee S; Rastogi S; Hsu DY; Nardone B; Silverberg JI
Arch Dermatol Res; 2021 Jul; 313(5):327-332. PubMed ID: 32647978
[TBL] [Abstract][Full Text] [Related]
2. Bullous pemphigoid and comorbidities: a case-control study in Portuguese patients.
Teixeira VB; Cabral R; Brites MM; Vieira R; Figueiredo A
An Bras Dermatol; 2014; 89(2):274-8. PubMed ID: 24770504
[TBL] [Abstract][Full Text] [Related]
3. Bullous pemphigoid in India: Review of cases registered in an autoimmune bullous disease clinic.
De D; Kaushik A; Handa S; Mahajan R; Chatterjee D; Saikia B; Saikia UN; Radotra BD; Minz RW
Indian J Dermatol Venereol Leprol; 2023; 89(4):553-557. PubMed ID: 35962510
[TBL] [Abstract][Full Text] [Related]
4. The association between neurological diseases, malignancies and cardiovascular comorbidities among patients with bullous pemphigoid: Case-control study in a specialized Polish center.
Kalińska-Bienias A; Kowalczyk E; Jagielski P; Bienias P; Kowalewski C; Woźniak K
Adv Clin Exp Med; 2019 May; 28(5):637-642. PubMed ID: 30784240
[TBL] [Abstract][Full Text] [Related]
5. Bullous pemphigoid and antecedent neurological diseases: An association with dementia.
Yu Phuan CZ; Yew YW; Tey HL
Indian J Dermatol Venereol Leprol; 2017; 83(4):457-461. PubMed ID: 28584223
[TBL] [Abstract][Full Text] [Related]
6. The association between bullous pemphigoid and comorbidities: a case-control study in Moroccan patients.
Titou H; Kerrouch H; Frikh R; Hjira N
Acta Dermatovenerol Alp Pannonica Adriat; 2022 Mar; 31(1):7-11. PubMed ID: 35339128
[TBL] [Abstract][Full Text] [Related]
7. Risk of Serious Infections in Patients with Bullous Pemphigoid: A Population-based Cohort Study.
Chang TH; Wu CY; Chang YT; Lyu YS; Wu CY
Acta Derm Venereol; 2023 Jun; 103():adv5329. PubMed ID: 37272362
[TBL] [Abstract][Full Text] [Related]
8. Association of Transient Palmoplantar Keratoderma With Clinical and Immunologic Characteristics of Bullous Pemphigoid.
Duretz C; Antonicelli F; Muller C; Antonicelli N; Plee J; Viguier M; Bernard P
JAMA Dermatol; 2019 Feb; 155(2):216-220. PubMed ID: 30484821
[TBL] [Abstract][Full Text] [Related]
9. Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland.
Benzaquen M; Borradori L; Berbis P; Cazzaniga S; Valero R; Richard MA; Feldmeyer L
J Am Acad Dermatol; 2018 Jun; 78(6):1090-1096. PubMed ID: 29274348
[TBL] [Abstract][Full Text] [Related]
10. [Bullous pemphigoid--a cause of itching of the skin with increasing incidence].
Huilaja L; Försti AK; Tasanen K
Duodecim; 2015; 131(16):1443-50. PubMed ID: 26485937
[TBL] [Abstract][Full Text] [Related]
11. Association of Immunosuppressants with Mortality of Patients with Bullous Pemphigoid: A Nationwide Population-Based Cohort Study.
Wu CY; Wu CY; Li CP; Lin YH; Chang YT
Dermatology; 2022; 238(2):378-385. PubMed ID: 34139703
[TBL] [Abstract][Full Text] [Related]
12. Comorbidities of bullous pemphigoid in a Finnish cohort.
Pankakoski A; Sintonen H; Ranki A; Kluger N
Eur J Dermatol; 2018 Apr; 28(2):157-161. PubMed ID: 29619987
[TBL] [Abstract][Full Text] [Related]
13. Neurological diseases and bullous pemphigoid: A case-control study in Iranian patients.
Daneshpazhooh M; Khorassani J; Balighi K; Ghandi N; Mahmoudi H; Tohidinik H; Hamzelou S; Chams-Davatchi C
Indian J Dermatol Venereol Leprol; 2017; 83(2):195-199. PubMed ID: 27679408
[TBL] [Abstract][Full Text] [Related]
14. Association between bullous pemphigoid and neurologic diseases: a case-control study.
Casas-de-la-Asunción E; Ruano-Ruiz J; Rodríguez-Martín AM; Vélez García-Nieto A; Moreno-Giménez JC
Actas Dermosifiliogr; 2014 Nov; 105(9):860-5. PubMed ID: 25004905
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study.
Cugno M; Marzano AV; Bucciarelli P; Balice Y; Cianchini G; Quaglino P; Calzavara Pinton P; Caproni M; Alaibac M; De Simone C; Patrizi A; Cozzani E; Papini M; Tedeschi A; Berti E; Rosendaal FR;
Thromb Haemost; 2016 Jan; 115(1):193-9. PubMed ID: 26245987
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T cell subsets in bullous pemphigoid and dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid.
Muramatsu K; Zheng M; Yoshimoto N; Ito T; Ujiie I; Iwata H; Shimizu H; Ujiie H
J Dermatol Sci; 2020 Oct; 100(1):23-30. PubMed ID: 32843228
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors for the Development of Bullous Pemphigoid in US Patients Receiving Immune Checkpoint Inhibitors.
Said JT; Liu M; Talia J; Singer SB; Semenov YR; Wei EX; Mostaghimi A; Nelson CA; Giobbie-Hurder A; LeBoeuf NR
JAMA Dermatol; 2022 May; 158(5):552-557. PubMed ID: 35416925
[TBL] [Abstract][Full Text] [Related]
18. Comorbid diseases among bullous pemphigoid patients in Germany: new insights from a case-control study.
Martin E; Mauer I; Malzahn U; Heuschmann PU; Goebeler M; Benoit S
J Dtsch Dermatol Ges; 2022 Jun; 20(6):798-805. PubMed ID: 35657083
[TBL] [Abstract][Full Text] [Related]
19. Multimorbidity in bullous pemphigoid: a case-control analysis of bullous pemphigoid patients with age- and gender-matched controls.
Sim B; Fook-Chong S; Phoon YW; Koh HY; Thirumoorthy T; Pang SM; Lee HY
J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1709-1714. PubMed ID: 28485892
[TBL] [Abstract][Full Text] [Related]
20. A Retrospective Study of Patient-Reported Data of Bullous Pemphigoid and Mucous Membrane Pemphigoid From a US-Based Registry.
Lee J; Seiffert-Sinha K; Attwood K; Sinha AA
Front Immunol; 2019; 10():2219. PubMed ID: 31608053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
